Early versus delayed or no empagliflozin initiation after hospitalisation for heart failure in the United States: A target trial emulation. (PubMed, ESC Heart Fail) - Sep 23, 2026 - "Early empagliflozin initiation was associated with lower risks of 1-year post-discharge all-cause mortality, worsening HF events, and all-cause hospitalisations compared with delayed or no initiation, and with lower acute care utilisation rates compared with no initiation."
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure
|
|
Atif Adam; Ayman Alhamdow; Giorgi Tskhvarashvili; Monica Martinez Traba; Niklas Schmedt; Phuong Tran; Ruben Hermans; Shirin Enshaeifar; Stephen J Greene
|